The Biosimilars Council released the following statement in response to the new MGA report authored by Alex Brill and Christy Robinson.
A new MGA white paper from CEO Alex Brill and Principal Christy Robinson shows a positive outlook for biosimilar coverage in the commercial medical benefit.
MGA releases an updated report, “Biosimilar Market Opportunities in Ophthalmology.”
MGA releases a new report, “Biosimilar Market Opportunities in Ophthalmology.”
In January 2015, CMS launched a star-rating system for U.S. dialysis facilities. This article analyzes nearly 6,000 U.S. dialysis facilities and explores trends and variations in star-rating scores based on facility characteristics and local demographic factors. Statistical tests show variation across states and by demographic factors.